Dental Supplies Distributor: Manufacturer vs Distributor and What to Verify

General information for clinic, lab and purchasing staff. It is not medical, legal or regulatory advice.

Short answer

A dental supplies distributor is a business that buys dental products from manufacturers and sells them on to practices and labs. Under FDA’s registration chart, a domestic distributor that does not import devices is not required to register, list devices or pay the fee, so there is no FDA registration for the distributor itself to look up. The registrations worth checking belong to the manufacturer, the initial importer, or any relabeler or repackager behind the product.

Definition and scope

This guide covers the supplier role in a dental purchase: who sits between the manufacturer and the practice, and what each party can be asked to show. It does not rank distributors, compare prices or recommend any company. For the products themselves, see the device-level guides on dental suction and saliva ejectors.

What is the difference between a manufacturer and a distributor?

FDA’s chart of who must register, list and pay the fee separates the roles that often get blurred in a purchase conversation. The table below reproduces the rows relevant to a dental buyer, with the CFR citation FDA gives for each.

Role (FDA wording)	Register	List devices	Pay fee	FDA citation
Domestic distributor that does not import devices	No	No	No	21 CFR 807.20(c)(3)
Initial importer	Yes	No (identifies the manufacturers)	Yes	21 CFR 807.40(a); 807.20(a)(5)
Relabeler or repackager	Yes	Yes	Yes	21 CFR 807.20(a)(3)
Contract manufacturer, including contract packagers	Yes	Yes	Yes	21 CFR 807.20(a)(2)
Specification developer	Yes	Yes	Yes	21 CFR 807.20(a)(1)

Source: FDA, “Who Must Register, List and Pay the Fee” (checked 2026-11-01; FDA marks the page current as of 09/27/2018). FDA describes an initial importer as an importer that moves a foreign manufacturer’s device toward its final sale or delivery to the user without repackaging it or altering its container, wrapper or labeling, and that must have a U.S. physical address staffed by people responsible for FDA compliance. A relabeler changes the content of the labeling supplied by the original manufacturer so the device can be distributed under its own name.

The practical consequence: one company can be a distributor for most of its catalogue and a relabeler or importer for some items. Its role can differ product by product.

Which certificates and registrations can I check independently?

FDA publishes a “Search Registration and Listing” tool through its Device Registration and Listing page (page current as of 09/30/2025, checked 2026-11-01). Because of the table above, the useful searches are for the manufacturer named on the label, and for the importer, relabeler or repackager if the label shows one. A search for a plain domestic distributor should not be expected to return a registration, and an empty result there is not a warning sign by itself.

A quality-system certificate is a separate question from FDA registration; see ISO 13485 certification for what that standard covers. Registration is also not a statement that FDA has approved or cleared a particular product.

How do I confirm a supplier is legitimate?

CASRAI does not issue verdicts on individual companies. What a buyer can do is establish, from documents, which role the supplier plays for each product and who stands behind it. A document-request list that follows from the role table:

• Manufacturer identity: the manufacturer name on the product label and instructions for use, and its FDA registration, which can be searched in FDA’s tool.
• Importer identity for foreign-made goods: FDA requires an initial importer to have a U.S. address staffed by people responsible for compliance of imported devices, so the importer should be nameable. See country-of-origin marking for imported medical devices.
• Relabeling: whether the supplier changes the labeling and sells under its own name. If so, FDA’s chart places it in the relabeler or repackager row, with registration and listing.
• Lot traceability: FDA’s recall rules say firms should code product for positive lot identification and keep distribution records that help locate recalled product (21 CFR 7.59). Ask how lot numbers are recorded against your order.
• Recall notification: who tells you, and how, when a product you bought is recalled (next section).

For institutions with formal onboarding, see hospital vendor credentialing.

How do I spot counterfeit or gray-market product?

This is covered in detail in gray-market medical supplies, which this guide does not repeat. The role table here adds one point: if a seller cannot name the manufacturer, or the importer for a foreign-made item, the chain back to a registered establishment is missing.

What do recall and returns terms look like?

Recall mechanics come from FDA’s regulations in 21 CFR Part 7, not from any distributor’s policy (eCFR text checked 2026-11-01):

• Classification (21 CFR 7.3(m)), assigned by FDA: Class I is a reasonable probability that use of or exposure to a violative product will cause serious adverse health consequences or death; Class II is a product that may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote; Class III is a product not likely to cause adverse health consequences.
• Recall communication (21 CFR 7.49): the notice to a direct account says the product is subject to a recall, that further distribution or use of remaining product should stop, that the account should in turn notify its own customers where appropriate, and gives instructions on what to do with the product.
• Recordkeeping (21 CFR 7.59): enough lot coding for positive lot identification, and distribution records kept long enough to help locate recalled product.

The Part 7 rules above cover recalls only. Return and credit arrangements for product that is not recalled are not addressed by them, so read those in the supplier’s written terms.

Dental office supply checklist: what this guide does and does not cover

For emergency-kit contents, see the dental office medical emergency supply checklist. For setting up a practice end to end, see how to start a dental practice. For infection-prevention expectations in dental settings, the CDC’s Summary of Infection Prevention Practices in Dental Settings (May 15, 2024) is the general reference.

Common misunderstandings

• “The distributor must be FDA registered.” Not for a domestic distributor that does not import, per FDA’s chart. The importer, relabeler and manufacturer are the registered roles.
• “Registered means approved.” Registration is an establishment-level status; it is not an FDA statement about any product.
• “A distributor is the same as a manufacturer.” FDA’s roles differ in what they must register and list.

FAQ

How do I become a medical supplies distributor?

On the federal device side, FDA’s chart states that a domestic distributor that does not import devices does not register, list or pay the fee (21 CFR 807.20(c)(3)). A business that imports devices becomes an initial importer and must register; one that relabels or repackages must register and list. This page covers only that federal FDA position. For selling to one specific kind of buyer, see how to sell medical supplies to the government.

How do I confirm a supplier is legitimate?

Ask which FDA role it holds for each product and for documents that name the manufacturer and, where relevant, the importer; check those registrations in FDA’s search tool.

What is the difference between a manufacturer and a distributor?

A manufacturer registers and lists its devices with FDA; a domestic distributor that does not import does neither (see the table).

Which certificates and registrations can I check independently?

FDA establishment registrations through FDA’s Registration and Listing search; quality-system certificates are a separate matter.

How do I spot counterfeit or gray-market product?

See gray-market medical supplies.

What do recall and returns terms look like?

Under 21 CFR 7.49, a recall communication tells direct accounts that further distribution or use of remaining product should stop and that they should notify their own customers; classes I to III describe the health hazard.

Sources

• FDA, Who Must Register, List and Pay the Fee (checked 2026-11-01).
• FDA, Device Registration and Listing (checked 2026-11-01).
• 21 CFR 807.20, Cornell LII (checked 2026-11-01).
• 21 CFR Part 7, eCFR: sections 7.3, 7.49 and 7.59 (checked 2026-11-01).
• CDC, Summary of Infection Prevention Practices in Dental Settings (May 15, 2024; checked 2026-11-01).